BMS PSP

BMS PSP

Patient Support Program

4 ratings
1 review

Details

  • Released
  • Updated
  • November 11, 2024
  • April 14, 2026
BMS PSP screenshot #1 for iPhone
BMS PSP screenshot #2 for iPhone
BMS PSP screenshot #3 for iPhone
BMS PSP screenshot #4 for iPhone
BMS PSP screenshot #5 for iPhone
BMS PSP screenshot #6 for iPhone
BMS PSP screenshot #7 for iPhone
BMS PSP screenshot #8 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

This program helps patients access innovative therapies by providing customized support. It facilitates access to specific medications for eligible patients who do not have full reimbursement.

Patient support programs
Access to innovative therapies
Customized patient assistance
Medication access facilitation
Support for specific medications
Show original description

What's New in BMS PSP

1.4

April 14, 2026

What’s New We’ve completely revamped the app to deliver a faster, smoother, and more intuitive experience. :sparkles: Brand-new modern design  :zap: Improved performance and speed  :bell: Enhanced notification reliability  :hammer_and_wrench: Bug fixes and stability improvements Update now to experience the all-new app!

More

User reviews

Broken app

App just doesn’t work and can’t login

Developer apps

FAQ

What is BMS PSP?

BMS PSP is a patient support program designed to help patients access innovative therapies from Bristol Myers Squibb. It provides customized assistance to ensure patients can obtain their prescribed medications.

Who is eligible for BMS PSP?

Eligibility for BMS PSP is for patients who have been prescribed Opdyta (Nivolumab) or Rojuzda (Luspatercept) by a healthcare professional for approved indications in India. Patients must not have any form of full reimbursement.

How can I enroll in BMS PSP?

Enrollment in BMS PSP is voluntary and requires a prescription from a healthcare professional. Patients can enroll to avail access to therapy based on the defined terms and conditions.

What medications are covered by BMS PSP?

Currently, BMS PSP is available for Opdyta (Nivolumab) and Rojuzda (Luspatercept). These are innovative therapies offered by Bristol Myers Squibb.

Is BMS PSP available outside of India?

Based on the current information, the program is described as applicable for patients in India. Specific details regarding international availability are not provided.

What is the age rating for BMS PSP?

BMS PSP has an age rating of 17+, indicating it is intended for adult users.

How often is BMS PSP updated?

The latest version of BMS PSP is 1.4, and it was last updated on April 14, 2026. This suggests a relatively recent update cycle.

Does BMS PSP have ads?

No, BMS PSP does not contain advertisements. The application is free to use and does not display any ads.